The idea that only certain targeted groups are most likely to be at risk is costly, both in terms of capital expenditure and in human lives. From a public-health standpoint, it's expensive. The new research is part of a national clinical trials network. It's to determine the benefits of the drugs. If there is too much money around, it's a waste of everyone's time and money.
Times are tight.
Only the best projects should be funded. This focused researcher also appreciates life's quirks of fate. Her packed schedule involves teaching, personnel issues, grant writing, committee meetings, conference attendance, and paper presentations. Graduating from Bates with a biology major and chemistry minor, Fiscus pursued a master's degree in botany at Duke. Degree in hand but unable to find a job in her field, she continued graduate work at Colorado State University in a doctoral program in viral immunology.